| Filed On | Filing |
|---|---|
| 31 Jul 2026 |
Form 4: Mohideen Pharis, Chief Medical Officer
Sold 464 shares ($1.25K) |
| 02 Feb 2026 |
Form 4: Mohideen Pharis, Chief Medical Officer
Sold 534 shares ($2.6K) |
| 14 Jan 2026 |
Form 4: Baker Bros. Advisors Lp, Director and 5 others
Exercised 27,304,896 BS Warrant · Acquired 27,304,896 Second Pre-Funded Warrant (Option Exercise/Conversion) |
| 19 Dec 2025 |
Form 4: Epic Bpifrance, Member of 10% owner group and 4 others
Sold 2,076,990 shares ($10.1M) · Sold 1,292,103 shares ($5.41M) |
| 25 Nov 2025 |
Form 4: Mohideen Pharis, Chief Medical Officer
Sold 6,496 shares ($18.7K) · Sold 1,624 shares ($4.5K) · Received 44,000 shares as a grant or award · 1 more |
| 24 Nov 2025 |
Form 4: Trapp Kevin Michael, Chief Commercial Officer
Received 55,000 shares as a grant or award · Granted 316,250 Employee Stock Option (right to buy) |
| 24 Nov 2025 |
Form 4: Boucinha Virginie, Chief Financial Officer
Received 32,000 shares as a grant or award · Granted 192,000 Employee Stock Option (right to buy) |
| 24 Nov 2025 |
Form 4: Tasse Daniel, Director
Granted 964,000 Employee Stock Option (right to buy) |
| 31 Jul 2025 |
Form 4: Mohideen Pharis, Chief Medical Officer
Sold 464 shares ($1.03K) |
| 27 May 2025 |
Form 4: Mohideen Pharis, Chief Medical Officer
Sold 397 shares ($730) |
| 31 Mar 2025 |
Form 4: Baker Bros. Advisors Lp, Director and 5 others
Granted 27,304,896 First Pre-Funded Warrant · Granted 27,304,896 BS Warrant |
| 31 Jan 2025 |
Form 4: Mohideen Pharis, Chief Medical Officer
Sold 600 shares ($510) |
| 05 Dec 2024 |
Form 4: Tasse Daniel, Director
Granted 813,200 Employee Stock Option (right to buy) |
| 27 Nov 2024 |
Form 4: Mohideen Pharis, Chief Medical Officer
Sold 342 shares ($181) · Sold 565 shares ($322) |
| 25 Nov 2024 |
Form 4: Mohideen Pharis, Chief Medical Officer
Received 35,000 shares as a grant or award · Sold 2,350 shares ($1.27K) · Granted 215,000 Employee Stock Option (right to buy) |
| 25 Nov 2024 |
Form 4: Boucinha Virginie, Chief Financial Officer
Received 19,000 shares as a grant or award · Granted 113,000 Employee Stock Option (right to buy) |
| 31 Jul 2024 |
Form 4: Mohideen Pharis, Chief Medical Officer
Sold 1,785 shares ($1.75K) |
| 29 May 2024 |
Form 4: Mohideen Pharis, Chief Medical Officer
Sold 382 shares ($527) · Sold 660 shares ($898) |
| 11 Mar 2024 |
Form 4: Tasse Daniel, Director
Bought 17,094 shares ($14.2K) |
| 08 Feb 2024 |
Form 4: Ndu Adora, Director
Bought 1,825 shares ($1.62K) |
Loading...